Altogether, our findings highlight the importance of circulating serum cortisol levels in humans (the equivalent of corticosterone in rodents) and insulin resistance as potential pre-symptomatic biomarkers in the AD pathology. This evidence concerns the gene INS and Alzheimer disease.